MRK logo

MRK
Merck & Co Inc

25,679
Mkt Cap
$374.8B
Volume
7.56M
52W High
$107.59
52W Low
$73.31
PE Ratio
13.92
MRK Fundamentals
Price
$105.26
Prev Close
$106.06
Open
$105.94
50D MA
$95.86
Beta
0.31
Avg. Volume
15.31M
EPS (Annual)
$6.74
P/B
5.05
Rev/Employee
$852,973.33
Loading...
Loading...
News
all
press releases
JB Capital LLC Boosts Holdings in Merck & Co., Inc. $MRK
JB Capital LLC lifted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 11.5% during the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
Stonebridge Financial Group LLC Has $638,000 Position in Merck & Co., Inc. $MRK
Stonebridge Financial Group LLC cut its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 76.8% in the third quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·17h ago
News Placeholder
Los Angeles Capital Management LLC Buys 956,879 Shares of Merck & Co., Inc. $MRK
Los Angeles Capital Management LLC lifted its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 39.0% in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·17h ago
News Placeholder
Can BMY's Growth Portfolio Drive Top-Line Expansion in 2026?
Bristol Myers Squibb's growth drugs rose 17% in the first nine months of 2025, helping offset a 16% legacy drug sales decline.
Zacks·18h ago
News Placeholder
VIRGINIA RETIREMENT SYSTEMS ET Al Has $126.51 Million Stock Holdings in Merck & Co., Inc. $MRK
VIRGINIA RETIREMENT SYSTEMS ET Al increased its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.6% in the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·18h ago
News Placeholder
Sax Wealth Advisors LLC Increases Position in Merck & Co., Inc. $MRK
Sax Wealth Advisors LLC increased its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 76.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·18h ago
News Placeholder
Smith Salley Wealth Management Reduces Stock Holdings in Merck & Co., Inc. $MRK
Smith Salley Wealth Management cut its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 74.9% during the 3rd quarter, according to the company in its most recent Form 13F filing...
MarketBeat·19h ago
News Placeholder
Calamos Advisors LLC Lowers Holdings in Merck & Co., Inc. $MRK
Calamos Advisors LLC lowered its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.4% in the third quarter, according to the company in its most recent 13F filing with the SEC...
MarketBeat·20h ago
News Placeholder
Merck & Co., Inc. $MRK Shares Sold by 3Chopt Investment Partners LLC
3Chopt Investment Partners LLC reduced its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 34.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·22h ago
News Placeholder
BMY vs AMGN: Which Biotech Stock Is More Resilient Now?
AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.
Zacks·1d ago
<
1
2
...
>

Latest MRK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.